Dementia clinical trial implications of mild behavioral impairment.

TitleDementia clinical trial implications of mild behavioral impairment.
Publication TypeJournal Article
Year of Publication2018
AuthorsMortby ME, Black SE, Gauthier S, Miller D, Porsteinsson A, Smith EE, Ismail Z
JournalInt Psychogeriatr
Volume30
Issue2
Pagination171-175
Date Published2018 Feb
ISSN1741-203X
Abstract

The World Alzheimer Report 2016 estimated that 47 million people are living with dementia worldwide (Alzheimer's Disease International, 2016). In the inaugural World Health Organization Ministerial Conference on Global Action against Dementia, six of the top ten research priorities were focused on prevention, identification, and reduction of dementia risk, and on delivery and quality of care for people with dementia and their carers (Shah et al., 2016). While the Lancet Neurology Commission has suggested that even minor advances to delay progression or ameliorate symptoms might have substantial financial and societal benefits (Winblad et al., 2016), advances have been slow.

DOI10.1017/S1041610218000042
Alternate JournalInt Psychogeriatr
PubMed ID29448970